High density lipoprotein subfractions and paraoxonase 1 in children

被引:9
作者
Muchova, Jana [1 ]
Andrezalova, Lucia [1 ]
Oravec, Stanislav [2 ]
Nagyova, Zuzana [3 ]
Garaiova, Iveta [4 ]
Durackova, Zdenka [1 ]
机构
[1] Comenius Univ, Fac Med, Inst Med Chem Biochem & Clin Biochem, Bratislava, Slovakia
[2] Comenius Univ, Fac Med, Dept Internal Med 2, Bratislava, Slovakia
[3] Juvenalia Paediat Ctr, Dunajska Streda, Slovakia
[4] Cultech Ltd, Res Dept, Unit, Port Talbot SA12 7BZ, Wales
关键词
lipoproteins; LDL-lipoproteins; HDL-lipoproteins; children; paraoxonase; 1; HOMOCYSTEINE-THIOLACTONASE ACTIVITY; SERUM PARAOXONASE; OXIDATIVE STRESS; HEART-DISEASE; HDL SUBCLASSES; PARTICLE-SIZE; PON1; PROTEIN; IN-VITRO; LDL; HYPERCHOLESTEROLEMIA;
D O I
10.18388/abp.2015_1230
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Lipoprint system (Quantimetrix Corp., CA, USA), enables the determination of 10 high density lipoprotein (HDL) subfractions in contrast to the 5 HDL subfractions that can be determined by ultracentrifuge analysis. HDL subfractions, and their relationships to the arylesterase (PON1-A) and lactonase (PON1-L) activities of paraoxonase 1 (PON1), together with total-, very low density lipoprotein- and low density lipoprotein (LDL)-cholesterol and LDL subfractions were investigated in the serum of 27 mildly hypercholesterolemic children and 21 healthy controls. Our results suggest the antiatherogenity of large HDL (L-HDL) subfractions and the atherogenity of small HDL (S-HDL) subfractions in the study groups. However, the relationship between the intermediate HDL (I-HDL) subfractions with the LDL subfractions and other lipoproteins did not suggest that I-HDL subfractions are antiatherogenic. No significant association between PON1-A and the HDL subfractions was found. In contrast, PON1-L activity positively correlated with the antiatherogenic large HDL1 subfraction and negatively with intermediate HDL subfractions 4, 5 and 6. Our results contribute to the knowledge of the roles of total HDL and ten individual HDL subfractions in children and adolescents.
引用
收藏
页码:555 / 563
页数:9
相关论文
共 50 条
  • [41] Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants
    Aviram, M
    Rosenblat, M
    Billecke, S
    Erogul, J
    Sorenson, R
    Bisgaier, CL
    Newton, RS
    La Du, B
    FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) : 892 - 904
  • [42] High Density Lipoprotein Associated Paraoxonase1 Activity in Relation to Oxidative Stress in CAD Patients
    Sharma, Ritu
    Singh, Balwant
    Mahajan, Mridula
    CURRENT CARDIOLOGY REVIEWS, 2006, 2 (02) : 125 - 129
  • [43] High-density lipoprotein composition and paraoxonase activity in Type I diabetes
    Valabhji, J
    McColl, AJ
    Schachter, M
    Dhanjil, S
    Richmond, W
    Elkeles, RS
    CLINICAL SCIENCE, 2001, 101 (06) : 659 - 670
  • [44] Paraoxonase genotype modifies the effect of pravastatin on high-density lipoprotein cholesterol
    Malin, R
    Laaksonen, R
    Knuuti, J
    Janatuinen, T
    Vesalainen, R
    Nuutila, P
    Lehtimäki, T
    PHARMACOGENETICS, 2001, 11 (07): : 625 - 633
  • [45] High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?
    Lappegard, Knut Tore
    Kjellmo, Christian Abendstein
    Hovland, Anders
    BIOMEDICINES, 2021, 9 (07)
  • [46] Alterations in plasma lipids, lipoproteins and high density lipoprotein subfractions in peripheral arterial disease
    Mowat, BF
    Skinner, ER
    Wilson, HM
    Leng, GC
    Fowkes, FGR
    Horrobin, D
    ATHEROSCLEROSIS, 1997, 131 (02) : 161 - 166
  • [47] High density lipoprotein subfractions and extent of coronary atherosclerotic lesions: From the cordioprev study
    de la Cruz-Ares, Silvia
    Leon-Acuna, Ana
    Yubero-Serrano, Elena M.
    Torres-Pena, Jose D.
    Arenas-de Larriva, Antonio P.
    Cardelo, Magdalena P.
    Rangel-Zuniga, Oriol A.
    Luque, Raul M.
    Alcala-Diaz, Juan F.
    Ordovas, Jose M.
    Perez-Martinez, Pablo
    Lopez-Miranda, Jose
    Delgado-Lista, Javier
    CLINICA CHIMICA ACTA, 2022, 533 : 89 - 95
  • [48] High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure
    Hammadah, Muhammad
    Kalogeropoulos, Andreas P.
    Georgiopoulou, Vasiliki V.
    Weber, Malory
    Wu, Yuping
    Hazen, Stanley L.
    Butler, Javed
    Tang, W. H. Wilson
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (06) : 748 - 755
  • [49] Benefits and Difficulties in Measuring HDL Subfractions and Human Paraoxonase-1 Activity During Statin Treatment
    Harangi, Mariann
    Seres, Ildiko
    Harangi, Janos
    Paragh, Gyoergy
    CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (06) : 501 - 510
  • [50] High-density lipoprotein subfractions and influence of endothelial lipase in a healthy Turkish population: A study in a land of low high-density lipoprotein cholesterol
    Kilic, Harun
    Atalar, Enver
    Lay, Incilay
    Yazihan, Nuray
    Buyukcam, Fatih
    Saygisunar, Ugur
    Aksoy, Murat
    Gunduz, Huseyin
    Akdemir, Ramazan
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2014, 74 (04) : 278 - 284